Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DIS vs GSK✓SelectedUSD · GSKDIS vs GSK performance historyLatest closeAs of-1.48%11/17
Stock and ETF performance explorer

DIS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+27.7%
GSK return
+104.0%
Excess return
-76.2%
Maximum drawdown
-60.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.5%-2.3%+0.8%-0.8%
7D-1.9%-3.0%+1.1%-1.1%
30D+5.7%+0.4%+5.4%+5.6%
3M+13.0%-1.2%+14.2%+13.2%
6M+14.7%+0.9%+13.8%+14.2%
YTD+3.6%+4.0%-0.4%+2.0%
1Y+12.2%+7.3%+5.0%+9.5%
3Y+28.1%+57.1%-29.0%+8.6%
5Y-23.3%+43.0%-66.3%-34.0%
10Y+27.7%+103.1%-75.3%-2.0%
All+27.7%+104.0%-76.2%-2.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling